ALCAM and breast carcinoma: In breast cancer, most of studies described that reduced ALCAM expression indicates a more aggressive phenotype and poor prognosis [16,17,18,19], whereas several studies showed that increased ALCAM expression is associated with poor prognosis [20,21,22].